nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—Amphetamine—SLC22A5—dilated cardiomyopathy	0.0104	0.519	CrCbGaD
Tolazoline—Methamphetamine—SLC22A5—dilated cardiomyopathy	0.00966	0.481	CrCbGaD
Tolazoline—ADRA2C—Metabolism—TAZ—dilated cardiomyopathy	0.00141	0.00144	CbGpPWpGaD
Tolazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00141	0.00144	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.0014	0.00143	CbGpPWpGaD
Tolazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.0014	0.00142	CbGpPWpGaD
Tolazoline—ADRA2C—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00139	0.00141	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00138	0.00141	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00138	0.00141	CbGpPWpGaD
Tolazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00137	0.0014	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00136	0.00138	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00136	0.00138	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00135	0.00137	CbGpPWpGaD
Tolazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00133	0.00135	CbGpPWpGaD
Tolazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00132	0.00135	CbGpPWpGaD
Tolazoline—ADRA2A—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.00131	0.00134	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.0013	0.00133	CbGpPWpGaD
Tolazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.0013	0.00133	CbGpPWpGaD
Tolazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.0013	0.00133	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00128	0.00131	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—SDHA—dilated cardiomyopathy	0.00128	0.0013	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00128	0.0013	CbGpPWpGaD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00127	0.0013	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00126	0.00129	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00126	0.00129	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00126	0.00129	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00124	0.00127	CbGpPWpGaD
Tolazoline—ADRA2A—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.00124	0.00126	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00123	0.00125	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00122	0.00125	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ANKRD1—dilated cardiomyopathy	0.00122	0.00125	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00121	0.00124	CbGpPWpGaD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00121	0.00123	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00119	0.00122	CbGpPWpGaD
Tolazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00118	0.0012	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00117	0.0012	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00116	0.00119	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—TAZ—dilated cardiomyopathy	0.00115	0.00117	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00113	0.00116	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00113	0.00115	CbGpPWpGaD
Tolazoline—ADRA2A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00113	0.00115	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00111	0.00114	CbGpPWpGaD
Tolazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.0011	0.00112	CbGpPWpGaD
Tolazoline—ADRA2B—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.00108	0.0011	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00106	0.00108	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00106	0.00108	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—ITGB1—dilated cardiomyopathy	0.00105	0.00107	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00104	0.00106	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—SDHA—dilated cardiomyopathy	0.00104	0.00106	CbGpPWpGaD
Tolazoline—ADRA2C—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.00101	0.00103	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00101	0.00103	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000989	0.00101	CbGpPWpGaD
Tolazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000982	0.001	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—ITGB1—dilated cardiomyopathy	0.000977	0.000997	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000969	0.000989	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000964	0.000984	CbGpPWpGaD
Tolazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000963	0.000983	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000938	0.000958	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000938	0.000958	CbGpPWpGaD
Tolazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00092	0.000939	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000919	0.000938	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000904	0.000922	CbGpPWpGaD
Tolazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000903	0.000922	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000898	0.000917	CbGpPWpGaD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000895	0.000914	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—CD36—dilated cardiomyopathy	0.000892	0.000911	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000877	0.000894	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000877	0.000894	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000872	0.00089	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000863	0.000881	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000856	0.000873	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000856	0.000873	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000852	0.00087	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000852	0.00087	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000845	0.000862	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—RAC1—dilated cardiomyopathy	0.000841	0.000858	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000839	0.000856	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—CD36—dilated cardiomyopathy	0.000834	0.000851	CbGpPWpGaD
Tolazoline—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000821	0.000838	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000821	0.000837	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000815	0.000832	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000796	0.000812	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000796	0.000812	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000796	0.000812	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000794	0.00081	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000792	0.000808	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000789	0.000805	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—RAC1—dilated cardiomyopathy	0.000786	0.000802	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000784	0.0008	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000781	0.000797	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000781	0.000797	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000771	0.000786	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000767	0.000783	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000766	0.000782	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000766	0.000782	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000748	0.000763	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00074	0.000755	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000734	0.000749	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000726	0.000741	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000722	0.000736	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000717	0.000731	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000712	0.000727	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000712	0.000727	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000712	0.000727	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000709	0.000724	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000709	0.000724	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000703	0.000717	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000696	0.00071	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000696	0.00071	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00069	0.000704	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000685	0.000699	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000682	0.000696	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	0.000677	0.000691	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000674	0.000688	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000662	0.000675	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000659	0.000673	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000658	0.000672	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000655	0.000669	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000647	0.00066	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000647	0.00066	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000647	0.00066	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000641	0.000654	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000639	0.000653	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000638	0.000652	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	0.000638	0.000651	CbGpPWpGaD
Tolazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000631	0.000644	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000627	0.000639	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000624	0.000637	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000622	0.000634	CbGpPWpGaD
Tolazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000619	0.000632	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000612	0.000625	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000601	0.000613	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.0006	0.000613	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000589	0.000601	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000582	0.000594	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000581	0.000593	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00057	0.000581	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000567	0.000579	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000559	0.00057	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—RAF1—dilated cardiomyopathy	0.000558	0.000569	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000547	0.000559	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000545	0.000556	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000544	0.000555	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000537	0.000548	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000535	0.000546	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000531	0.000542	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00053	0.00054	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—RAF1—dilated cardiomyopathy	0.000521	0.000532	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000519	0.00053	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000517	0.000528	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000508	0.000518	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000508	0.000518	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000503	0.000514	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000503	0.000514	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000497	0.000507	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000496	0.000507	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000485	0.000495	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000483	0.000492	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000474	0.000484	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000472	0.000481	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000472	0.000481	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00047	0.00048	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00047	0.00048	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000468	0.000478	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000463	0.000473	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000463	0.000472	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000461	0.000471	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000453	0.000463	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000451	0.00046	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000442	0.000451	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000437	0.000446	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000434	0.000443	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000431	0.00044	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00043	0.000439	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000423	0.000432	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	0.000423	0.000432	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000423	0.000431	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000419	0.000427	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000419	0.000427	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000415	0.000423	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000411	0.000419	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000411	0.000419	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000403	0.000411	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000402	0.00041	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000394	0.000402	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000389	0.000397	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000387	0.000395	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000385	0.000393	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000384	0.000392	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000382	0.00039	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000382	0.00039	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000382	0.00039	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000377	0.000385	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000377	0.000384	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000373	0.000381	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00037	0.000378	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000367	0.000375	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000366	0.000374	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000362	0.000369	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000355	0.000362	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00035	0.000357	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	0.000347	0.000354	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000344	0.000351	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000343	0.00035	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	0.000338	0.000345	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000322	0.000329	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000321	0.000328	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00032	0.000327	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000316	0.000323	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000316	0.000322	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000306	0.000312	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	0.000304	0.000311	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.0003	0.000306	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000299	0.000305	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000295	0.000301	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000294	0.0003	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000285	0.000291	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	0.000282	0.000288	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000279	0.000284	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	0.000275	0.00028	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000272	0.000278	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000266	0.000272	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000266	0.000272	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000263	0.000268	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000261	0.000267	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000258	0.000263	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	0.000254	0.00026	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	0.000247	0.000252	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000243	0.000248	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000239	0.000244	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000237	0.000242	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000233	0.000238	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000227	0.000231	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000222	0.000227	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—EGFR—dilated cardiomyopathy	0.00022	0.000225	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000219	0.000224	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000216	0.000221	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000207	0.000211	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000205	0.000209	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000189	0.000193	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000183	0.000186	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000179	0.000183	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000177	0.00018	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000166	0.00017	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000157	0.000161	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000154	0.000158	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000143	0.000146	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	0.00013	0.000132	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000121	0.000124	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000108	0.00011	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000106	0.000108	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	9.84e-05	0.0001	CbGpPWpGaD
